DXCM
DexCom Inc
DexCom Inc historical holders
total: 5
Lone Pine Capital DexCom Inc transactions over time
- Total transactions:
- 9
- New positions:
- 2
- Sold out:
- 2
- Added:
- 3
- Reduced:
- 2
- Held since:
- 2020 Q2
- Held for:
- 6 quarters
- Latest activity:
- 2021 Q4
Stephen Mandel has been an institutional investor in DexCom Inc (DXCM) since 2019 Q4. According to 2026 Q1 report, Stephen Mandel doesn't hold any shares. The fund/company first acquired DXCM in 2019 Q4, initially purchasing about 4.24M shares. Stephen Mandel later completely sold out the position and reinvested in DXCM again in 2020 Q2. Since the initial investment, Lone Pine Capital has made 8 more transactions in this position.
When did Stephen Mandel exit their DXCM position?
Stephen Mandel no longer holds DexCom Inc (DXCM). They sold off their entire position in 2021 Q4, closing out an investment that began in 2019 Q4.
When did Stephen Mandel first invest in DXCM?
Stephen Mandel first invested in DexCom Inc (DXCM) in 2019 Q4 at the reported quarter-end price of $54.69 per share, acquiring 4,235,580 shares in their initial purchase.
What is Stephen Mandel's average cost basis for DXCM?
Based on historical transaction data, Stephen Mandel's estimated cost basis for DexCom Inc (DXCM) is approximately $94.15 per share. This represents their average reported price* across all buy transactions.
Has Stephen Mandel reinvested in DXCM after selling?
Yes, Stephen Mandel has shown renewed interest in DexCom Inc (DXCM). After completely selling their position, they reinitiated an investment in 2020 Q2, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $94.14
- Weighted AVG sell price:
- $130.34
DXCM transactions history by Lone Pine Capital
9 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q4
|
0.00%
|
0
|
$136.71
|
|
-100% (-5,764,908)
|
-2.66%
|
|
2021 Q3
|
2.66%
|
5,764,908
|
$136.71
|
$788,149,000
|
-22.86% (-1,708,240)
|
-0.75%
|
|
2021 Q2
|
2.57%
|
7,473,148
|
$106.75
|
$797,759,000
|
-21.27% (-2,019,444)
|
-0.78%
|
|
2021 Q1
|
3.10%
|
9,492,592
|
$89.85
|
$852,886,000
|
+4.64% (+421,356)
|
+0.14%
|
|
2020 Q4
|
3.05%
|
$92.43
|
+389.72% (+7,218,888)
|
|||
|
2020 Q3
|
0.82%
|
$103.06
|
+36.38% (+494,164)
|
|||
|
2020 Q2
|
0.71%
|
$101.35
|
new
|
|||
|
2020 Q1
|
0.00%
|
$54.69
|
-100% (-4,235,580)
|
|||
|
2019 Q4
|
1.24%
|
$54.69
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.